⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ENTX News

Entera Bio Ltd. Ordinary Shares

Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting